OOIR: Observatory of International Research

Papers

(The H4-Index of Molecular Therapy-Oncolytics is 35. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)

Article	Citations
CXCR1 Expression to Improve Anti-Cancer Efficacy of Intravenously Injected CAR-NK Cells in Mice with Peritoneal Xenografts	87
Regulation of Glycolysis by Non-coding RNAs in Cancer: Switching on the Warburg Effect	84
B7-H3-Targeted CAR-T Cells Exhibit Potent Antitumor Effects on Hematologic and Solid Tumors	67
Targeting YTHDF1 effectively re-sensitizes cisplatin-resistant colon cancer cells by modulating GLS-mediated glutamine metabolism	66
Efficacy and Safety of CD28- or 4-1BB-Based CD19 CAR-T Cells in B Cell Acute Lymphoblastic Leukemia	65
Molecular profiles of small cell lung cancer subtypes: Therapeutic implications	61
Long non-coding RNAs: Biogenesis, functions, and clinical significance in gastric cancer	58
CAR T cell therapy and the tumor microenvironment: Current challenges and opportunities	57
Rapidly Switchable Universal CAR-T Cells for Treatment of CD123-Positive Leukemia	57
M2 macrophage-derived exosomal microRNA-155-5p promotes the immune escape of colon cancer by downregulating ZC3H12B	52
Tumor-Secreted Exosomal lncRNA POU3F3 Promotes Cisplatin Resistance in ESCC by Inducing Fibroblast Differentiation into CAFs	52
Characterization of the fatty acid metabolism in colorectal cancer to guide clinical therapy	48
Efficacy of a Third-Generation Oncolytic Herpes Virus G47Δ in Advanced Stage Models of Human Gastric Cancer	46
Fascin actin-bundling protein 1 in human cancer: Promising biomarker or therapeutic target?	46
Carboranes as unique pharmacophores in antitumor medicinal chemistry	46
Analysis of Lung Adenocarcinoma Subtypes Based on Immune Signatures Identifies Clinical Implications for Cancer Therapy	45
ENO1 and Cancer	43
Systematic profiling of ferroptosis gene signatures predicts prognostic factors in esophageal squamous cell carcinoma	43
In Vitro and MD Simulation Study to Explore Physicochemical Parameters for Antibacterial Peptide to Become Potent Anticancer Peptide	42
Single-cell RNA sequencing in cancer: Applications, advances, and emerging challenges	42
Natural Killer Cells: Diverse Functions in Tumor Immunity and Defects in Pre-neoplastic and Neoplastic Stages of Tumorigenesis	41
Engineering Chimeric Antigen Receptor T Cells against Immune Checkpoint Inhibitors PD-1/PD-L1 for Treating Pancreatic Cancer	40
Engineered CAR-T cells targeting TAG-72 and CD47 in ovarian cancer	40
Tumor microenvironment and immune-related therapies of head and neck squamous cell carcinoma	39
CircRHBDD1 augments metabolic rewiring and restricts immunotherapy efficacy via m6A modification in hepatocellular carcinoma	38

CAR-T Cells Targeting Epstein-Barr Virus gp350 Validated in a Humanized Mouse Model of EBV Infection and Lymphoproliferative Disease	37
Metformin enhances anti-cancer effects of cisplatin in meningioma through AMPK-mTOR signaling pathways	37
Tumor immune microenvironment-based classifications of bladder cancer for enhancing the response rate of immunotherapy	37
Valeric Acid Suppresses Liver Cancer Development by Acting as a Novel HDAC Inhibitor	37
Viral Delivery of CAR Targets to Solid Tumors Enables Effective Cell Therapy	36
Oncolytic herpes virus G47Δ works synergistically with CTLA-4 inhibition via dynamic intratumoral immune modulation	36
Chimeric Antigen Receptor T Cell Therapy Targeting ICAM-1 in Gastric Cancer	36
Route of 41BB/41BBL Costimulation Determines Effector Function of B7-H3-CAR.CD28ζ T Cells	36
The next wave of cellular immunotherapies in pancreatic cancer	35
The emerging role of off-the-shelf engineered natural killer cells in targeted cancer immunotherapy	35